In addition, CDK, mTOR, and DNA Repair pathways have also been previously shown to be enriched in BrM arising from BC and other solid tumors [7], and have become the focus of genomically-guided, prospective clinical trials in the BrM space (NCT03994796). Here, MTOR is linked to breast cancer.